Capital Analysts buys $5,261,494 stake in CVS Health Corp (CVS)

CVS Health Corp (CVS) : Capital Analysts scooped up 1,643 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 14, 2016. The investment management firm now holds a total of 54,315 shares of CVS Health Corp which is valued at $5,261,494.CVS Health Corp makes up approximately 1.04% of Capital Analysts’s portfolio.

Other Hedge Funds, Including , Johanson Financial Advisors boosted its stake in CVS in the latest quarter, The investment management firm added 206 additional shares and now holds a total of 6,021 shares of CVS Health Corp which is valued at $583,254. CVS Health Corp makes up approx 0.67% of Johanson Financial Advisors’s portfolio.Fisher Asset Management reduced its stake in CVS by selling 12,541 shares or 8.81% in the most recent quarter. The Hedge Fund company now holds 129,783 shares of CVS which is valued at $12,670,714. CVS Health Corp makes up approx 0.02% of Fisher Asset Management’s portfolio.North Star Investment Management Corp. reduced its stake in CVS by selling 26 shares or 3.31% in the most recent quarter. The Hedge Fund company now holds 760 shares of CVS which is valued at $74,199. CVS Health Corp makes up approx 0.01% of North Star Investment Management Corp.’s portfolio. Searle sold out all of its stake in CVS during the most recent quarter. The investment firm sold 27,398 shares of CVS which is valued $2,674,867.

CVS Health Corp closed down -0.22 points or -0.23% at $96.87 with 35,71,222 shares getting traded on Monday. Post opening the session at $97.44, the shares hit an intraday low of $96.7637 and an intraday high of $97.69 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.

Many Wall Street Analysts have commented on CVS Health Corp. Shares were Reiterated by Mizuho on Jun 23, 2016 to “Buy” and Lowered the Price Target to $ 108 from a previous price target of $117 .Shares were Reiterated by Deutsche Bank on Jun 22, 2016 to “Hold” and Lowered the Price Target to $ 99 from a previous price target of $105 .CVS Health Corp was Downgraded by Morgan Stanley to ” Equal-Weight” on Jun 20, 2016.

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *